Elsevier

Tetrahedron

Volume 96, 10 September 2021, 132402
Tetrahedron

Tetrahedron report 1241
Recent advances of the site-specific direct methylation on aromatic rings

https://doi.org/10.1016/j.tet.2021.132402Get rights and content

Abstract

Five- and six-membered aromatic rings bearing a methyl group are important molecular fragments in drug discovery. From the medicinal chemistry standpoint, the methyl group might play a pivotal role in improving the biological activities and druggability due to its capability in modulating the molecular conformation as well as the physical and chemical properties (such as lipophilicity and metabolism, etc.). How to effectively install a methyl group in a designated position of an aromatic ring is a long-stand quest and a research hot spot for both medicinal chemists and synthetic organic chemists. In the past few years, significant progresses have been achieved in this field wherein the C–H bond activation and direct methylation become achievable in one step under catalytic conditions. A variety of metal catalysts reported by several research groups are capable of such transformation. The relatively mild reaction conditions and high functional group compatibility make such transformation very attractive for final step synthesis. This paper summarizes such transformation based on their reaction mechanisms, and systematically discusses the reaction conditions and their application of a variety of substrates. It provides both medicinal and synthetic organic chemists the convenience for accessing the most up-to-date methodology, and would foster the potential applications in drug discovery and organic synthesis projects.

Graphical abstract

Focusing on the site-specific direct methylation on aromatic rings, this paper discusses the recent progresses in two different categories based on the mechanisms of the C–H bond breakage: the directing group (DG) mediated method and the radical approach. It provides both medicinal chemists and synthetic organic chemists the convenience for accessing the most up-to-date methodology and would foster the potential applications in drug discovery and organic synthesis projects.

Image 1
  1. Download : Download high-res image (193KB)
  2. Download : Download full-size image

Introduction

In view of atom economic and eco-friendly process, the selective functionalization of carbon-hydrogen bonds (C–H) via directing group (DG) mediated approach or radical approach is an extremely important topic in today's organic synthesis [1,2]. Among the direct functionalization of a C–H bond, direct alkylation represents an important subclass organic transformation, which can introduce a preferred alkyl group into aryl or heteroaryl ring systems. A review article published recently by Punji et al. summarized the progresses of the direct alkylation of unactivated hydrocarbons and heteroaromatics with limited efforts devoted to direct methylation examples [3]. It has been well documented that aromatic rings bearing a methyl group are common fragments in drugs and bioactive molecules [4,5]. The methyl group is capable of changing the molecular conformation, lipophilicity, and metabolism of the drug candidates, hence affecting biological activities, pharmacokinetic parameters, and pharmacodynamic effects [[6], [7], [8], [9], [10], [11]]. Analyses of the literature reveal that in about 8 % of the cases a methyl group show more than 10 times improvement in biological activities. Furthermore, in about 0.5 % of the cases, a “magic” methyl group could improve the biological activities greater or equal to 100-fold [12].

Fig. 1 listed three examples where the “magic” methyl group enhances the biological activities. The introduction of dimethyl at the ortho-position of the left side aniline of ACK1 inhibitor 1 improves the activity more than 1000 fold (2 vs 1) due to the more lipophilic 2,6-dimethyl aniline better fitting into the hydrophobic region arranged by the side chains of Ile190, Leu259, and Phe271. The second example is about phenylthiophene inhibitors of PTP1B. The methyl group at C4 of the thiophene ring positions into a well-formed hydrophobic pocket lined by the side chain of Ile219 and Cβ and Cγ of Gln262, contributing to the significant activity improvement (4 vs 3). In the last example, the introduction of a methyl group to thrombin inhibitor 5 enhances hydrophobic contacts and conformational bindings of the inhibitor to the protein, resulting in greater than 180 fold increase of the Ki value (6 vs 5).

Additionally, the methyl group on aromatic rings can also serve as an important surrogate for generating various functional groups such as aldehyde, carboxylic acid, alcohol, halogenated methyl, or directly be used in C–N coupling reactions [13]. Those functional groups are either important fragments or useful building blocks in organic synthesis. Therefore, the facile installation of a methyl group is very important for medicinal chemists in drug discovery programs, especially when such transformation is demanded as the last step process. Several previously reviewed methylation reactions for transforming a C-X bond (wherein X is a leaving group such as halogen [14], OTf, OTs, OMs, Bpin [15], etc.) to a C–Me bond have been well documented in the literature, for example, Stille coupling reaction, the organocuprate approach, and the halogen-metal exchange protocol etc. However, the X surrogates demanded by in convention methods might not be compatible in one of the reaction steps during the synthetic sequence. In addition, these X surrogates need to be pre-installed using extra synthetic steps, making those methods less attractive due to the relative low atom economy and atom efficiency (Fig. 2). In the past few years, the catalytic C–H bond activation and simultaneous methylation on a site-specific aromatic ring have attracted great attention from the organic chemistry community. Schnürch et al. gave a comprehensive overview of the advances of C–H bond functionalization from 2015 to 2017 [16]. However, the review only focused on the metal-mediated directing group approaches, and did not cover the radical approaches. Early this year, Dixon et al. gave a high level review on the advances of the direct methylation on sp2 and sp3 carbons [17]. However their review did not list comprehensive up-to-date examples of the direct methylation of aromatic rings. Due to the rapid advancement in this field, it's necessary to summarize the most recent developments. This article aims to summarize the recent advances of the direct methylation on aromatic rings using both the DG mediated method and the radical approach. It will cover these examples did not appear in previous review articles.

Section snippets

Directing group mediated methods

In organic molecules, the reactivity and selectivity between typical C–H bonds are often difficult to be distinguished due to the relatively similar energy level required to break them [1,18]. Therefore, a DG is often needed to help orientate or facilitate a reaction through chelation, interaction, or coordination with a reagent [4]. With the assistance of a DG, the C–H bond on an aromatic ring can be activated in a site-specific manner (typically at the o-position of DG), and the resulting C–H

Radical approach

Free radical reaction is one of the most important reaction types and has been widely used in natural product synthesis, medicinal chemistry, and materials science [42]. A new methylation method has been developed to utilizing this type of reaction. This approach involves a methyl radical, and no metal-chelating complex in a transition state is required. More specifically, a methyl radical generated from a reagent initiates the uniform cleavage of the C–H bond at the specific site of the

Direct methylation at the 2-position of pyridine

Direct methylation at the o-position of pyridine nitrogen has been reported in 2008 by Kleeberg et al. [54] using Acros Raney nickel as the catalyst. In Kleeberg's method, n-decyl alcohol is used as both the solvent and the methylating reagent (Fig. 45). In the presence of nickel catalysts, primary alcohols decompose at elevated temperatures into carbon monoxide and hydrocarbon. The carbon monoxide is probably the methylation source. Upon prolonging heating with the catalyst Acros Raney nickel,

Conclusions and outlook

Centering on the direct methylation of aromatic rings, the article summarizes the recent advances in this field in two categories: DG-mediated approach and radical approach. Comparing with the conventional approaches for installing methyl group, the methods discussed here have many advantages. Firstly, they do not need the pre-installation of a leaving group surrogate as needed in previously reviewed methylation reactions. Secondly, many of the methods discussed here have good compatibility

Declaration of competing interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Acknowledgments

This work was supported by the National Natural Science Foundation of China (82073686, 81730108, and 81973635), Hangzhou Normal University startup fund (4125C5021920419), the Ministry of Science and Technology of China (High-end foreign experts program, G20200217005), Hangzhou's “115” plan to introduce overseas intelligence projects (20200215), Hangzhou Normal University, School of Medicine Teaching Reform Fund (4125b30100112).

Mr. Mao is currently the first year student working on his Master degree at Hangzhou Normal University.

References (61)

  • Z. Shen et al.

    Org. Lett.

    (2019)
  • S. Sun et al.

    Bioorg. Med. Chem. Lett

    (2018)
  • D. Liu et al.

    Eur. J. Org Chem.

    (2019)
  • Z. Li et al.

    Org. Chem. Front.

    (2017)
  • Q. Sun et al.

    Org. Chem. Front.

    (2018)
  • W. Lv et al.

    J. Org. Chem.

    (2019)
  • E. Weis et al.

    iScience

    (2021)
  • Z.-L. Li et al.

    Org. Chem. Front.

    (2019)
  • T. Kubo et al.

    Org. Lett.

    (2016)
  • H. Wang et al.

    Org. Lett.

    (2016)
  • T. Sato et al.

    Org. Lett.

    (2017)
  • B. Wang et al.

    Adv. Synth. Catal.

    (2017)
  • W. An et al.

    Org. Lett.

    (2020)
  • A. Shamsabadi et al.

    Org. Biomol. Chem.

    (2019)
  • X. Rong et al.

    Asian J. Org. Chem.

    (2020)
  • S. Jin et al.

    Org. Biomol. Chem.

    (2020)
  • J. Genovino et al.

    Org. Lett.

    (2018)
  • W. Liu et al.

    Inside Chem.

    (2017)
  • Z. Liu et al.

    Org. Lett.

    (2017)
  • J. Das et al.

    ACS Catal.

    (2021)
  • M.J. Jang et al.

    Bull. Kor. Chem. Soc.

    (2011)
  • S.B. Ankade et al.

    ACS Catal.

    (2021)
  • M.D.L. Tonin et al.

    Synthesis

    (2017)
  • S.D. Friis et al.

    Nat. Chem.

    (2020)
  • Q. Gao et al.

    J. Am. Chem. Soc.

    (2019)
  • J. Wencel-Delord

    Nat. Chem.

    (2020)
  • E.B. Corcoran et al.

    Nature

    (2020)
  • T. Cernak et al.

    Angew. Chem. Int. Ed.

    (2013)
  • C.S. Leung et al.

    J. Med. Chem.

    (2012)
  • S.K. Kariofillis et al.

    J. Am. Chem. Soc.

    (2020)
  • Cited by (8)

    View all citing articles on Scopus

    Mr. Mao is currently the first year student working on his Master degree at Hangzhou Normal University.

    Dr. Yang Ye obtained his Ph.D. from Shanghai University (with Prof. Hegui Gong). Then he joined the faculty in School of Pharmacy, Hangzhou Normal University in 2021. His research interests focus on the development of synthetic methods for C–C formation and the application of these methods in drug discovery programs.

    Dr. Zhuo obtained his Ph.D. in 2013 from the Department of Chemistry, Lanzhou University, majoring in organic chemistry. He then spent 10 years in pharmaceutical companies working on drug design and drug synthesis. He is currently a lecturer at Hangzhou Normal University.

    Prof. Xiang-Yang Ye obtained his Ph.D. in 1999 from The University of Hong Kong under the supervision of Prof. Dan Yang. He then spent 3 years at Princeton University as postdoc researcher under the supervision of Profs. Dan Kahne and Suzanne Walker. From 2002 to 2016, he worked in the Pharmaceutical Research Institute at Bristol-Myers Squibb Company, first as Research Investigator and ultimately promoted to Principal Scientist. Since December 2018, he is a professor at Hangzhou Normal University. His research interests center on drug discovery in the field of oncology, metabolic diseases, and immunology.

    Dr. Tian Xie holds MD degree, and is currently Professor of School of Pharmacy and Holistic Integrative Oncology Institutes at Hangzhou Normal University. He is also the director of the Key Laboratory of Elemene Class Anti-cancer Chinese Medicine of Zhejiang Province and the head of the Engineering Laboratory of Development and Application of Traditional Chinese Medicine from Zhejiang Province. Dr. Xie has been engaged in research, teaching and industrialization of Chinese and Western Medicine, natural medicine research and development, targeted liposomes development, pharmaceutical engineering, and green chemistry for more than 40 years.

    1

    These authors contributed equally to this work.

    View full text